Although there are limited studies explaining the association between sarcopenia risk and low CD4 T-cell count, systemic inflammation and increased immune activation caused by disease progression contribute to muscle mass loss and sarcopenia development.31 The gene discussed is CD4; the disease is sarcopenia.